Notice2022-02199

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
February 3, 2022

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 23 (Thursday, February 3, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 23 (Thursday, February 3, 2022)]
[Notices]
[Page 6178]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-02199]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Therapeutic Development and Preclinical Studies.
    Date: March 3-4, 2022.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Richard D. Schneiderman, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4138, Bethesda, MD 20817, 301-
402-3995, <a href="/cdn-cgi/l/email-protection#eb998288838a998fc5988883858e828f8e99868a85ab858283c58c849d"><span class="__cf_email__" data-cfemail="6b190208030a190f45180803050e020f0e19060a052b050203450c041d">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR 20-117: Maximizing Investigators' Research Award (MIRA) 
for Early Stage Investigators (R35--Clinical Trial Optional).
    Date: March 7-8, 2022.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Altaf Ahmad Dar, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 415-254-1803, 
<a href="/cdn-cgi/l/email-protection#c0a1acb4a1a6eea4a1b280aea9a8eea7afb6"><span class="__cf_email__" data-cfemail="0f6e637b6e69216b6e7d4f61666721686079">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Innovative Immunology.
    Date: March 9, 2022.
    Time: 10:00 a.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Dayadevi Balappa Jirage, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6700B Rockledge Drive, Room 4422, Bethesda, MD 20892, (301) 
867-5309, <a href="/cdn-cgi/l/email-protection#214b48534046444543614252530f4f48490f464e57"><span class="__cf_email__" data-cfemail="23494a514244464741634050510d4d4a4b0d444c55">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Bioengineering, Surgery, Anesthesiology and 
Trauma.
    Date: March 9, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Donald Scott Wright, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 
20892, (301) 435-8363, <a href="/cdn-cgi/l/email-protection#f98e8b909e918d9d8ab99a8a8bd7979091d79e968f"><span class="__cf_email__" data-cfemail="ef989d8688879b8b9caf8c9c9dc1818687c1888099">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Electronic Nicotine Delivery Systems and Tobacco Use.
    Date: March 9, 2022.
    Time: 11:00 a.m. to 9:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kimm Hamann, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4118A, MSC 7814, Bethesda, MD 20892, 301-435-
5575, <a href="/cdn-cgi/l/email-protection#6a020b070b040401002a09191844040302440d051c"><span class="__cf_email__" data-cfemail="aec6cfc3cfc0c0c5c4eecddddc80c0c7c680c9c1d8">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Skeletal Muscle and Exercise Physiology.
    Date: March 9, 2022.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Carmen Bertoni, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 805B, Bethesda, MD 20892, (301) 
867-5309, <a href="/cdn-cgi/l/email-protection#a5c7c0d7d1cacbccc697e5c6d6d78bcbcccd8bc2cad3"><span class="__cf_email__" data-cfemail="066463747269686f65344665757428686f6e28616970">[email&#160;protected]</span></a>.

    Name of Committee: Infectious Diseases and Immunology B 
Integrated Review Group; Clinical Research and Field Studies of 
Infectious Diseases Study Section.
    Date: March 10-11, 2022.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Pauline Cupit, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, 301-827-3275, 
<a href="/cdn-cgi/l/email-protection#741701041d0017011a1a1d1a131c04193419151d185a1a1d1c5a131b02"><span class="__cf_email__" data-cfemail="432036332a3720362d2d2a2d242b332e032e222a2f6d2d2a2b6d242c35">[email&#160;protected]</span></a>.

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group; Innate Immunity and Inflammation Study 
Section.
    Date: March 10-11, 2022.
    Time: 9:30 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Shahrooz Vahedi, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 810G, Bethesda, MD 20892, (301) 
496-9322, <a href="/cdn-cgi/l/email-protection#5c2a3d343938352f1c313d353072323534723b332a"><span class="__cf_email__" data-cfemail="dcaabdb4b9b8b5af9cb1bdb5b0f2b2b5b4f2bbb3aa">[email&#160;protected]</span></a>.

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group; Maximizing Investigators' 
Research Award B Study Section.
    Date: March 10-11, 2022.
    Time: 10:00 a.m. to 9:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sudha Veeraraghavan, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4166, MSC 7846, Bethesda, MD 
20892, (301) 827-5263, <a href="/cdn-cgi/l/email-protection#532026373b327d25363621322132343b3225323d133d3a3b7d343c25"><span class="__cf_email__" data-cfemail="94e7e1f0fcf5bae2f1f1e6f5e6f5f3fcf5e2f5fad4fafdfcbaf3fbe2">[email&#160;protected]</span></a>.

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Cellular and Molecular Biology 
of Neurodegeneration Study Section.
    Date: March 10-11, 2022.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Laurent Taupenot, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4188, MSC 7850, Bethesda, MD 
20892, 301-435-1203, <a href="/cdn-cgi/l/email-protection#117d706463747f653f65706461747f7e65517f78793f767e67"><span class="__cf_email__" data-cfemail="d8b4b9adaabdb6acf6acb9ada8bdb6b7ac98b6b1b0f6bfb7ae">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 28, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02199 Filed 2-2-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on February 3, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.